[Therapeutic studies with branched-chain amino acids in portasystemic encephalopathy].
Published controlled clinical trials with branched chain amino acids (BCAA) in patients with portosystemic encephalopathy (PSE) are described and their results discussed. A positive effect on PSE by BCAA seems probable but without altering mortality rate. Improvement of nutritional state cannot be finally evaluated.